Sort
48,018 grants matching “immunotherapy”
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$440,990Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Physical Resistance to Immune Cell Attack by the Cellular Glycocalyx
$440,955Matthew J Paszek · Cornell University · R01 · FY2025 · CA
Neoadjuvant immunotherapy approaches to early stage melanoma
$440,937Meenhard Herlyn · Wistar Institute · P50 · FY2023 · CA
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma
$440,932Michael Richard Green · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Analysis of Fel d 1-specific T cells after airway allergen challenge in asthma
$440,912Gail M Gauvreau · Mcmaster University · U19 · FY2016 · AI
Analysis of Fel d 1-specific T cells after airway allergen challenge in asthma
$440,912Gail M Gauvreau · Mcmaster University · U19 · FY2015 · AI
CEA TARGETED IMMUNOTHERAPEUTICS
$440,896Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2010 · CA
Comprehensive identification of germline-somatic interactions
$440,864Hannah Kathryn Carter · University Of California, San Diego · R01 · FY2023 · CA
Project 3: Phase-2 Trial of Oncolytic Poliovirus (PVSRIPO) combined with CCNU (lomustine) against Recurrent Glioblastoma
$440,797Darell D Bigner · Duke University · P01 · FY2018 · CA
Development of Chimeric Antigen Receptor Phagocytes Against Glioblastoma
$440,781Siddhartha S. Mitra · University Of Colorado Denver · R01 · FY2025 · CA
Mechanisms Underlying the Role of Interleukin-7 in Type 1 Diabetes
$440,718Hans Peter Dooms · Boston University Medical Campus · R01 · FY2019 · DK
Exploration of different immunotherapy modalities in osteosarcoma
$440,640Payal Agarwal · Auburn University At Auburn · R15 · FY2023 · CA
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
$440,630Bruce K Walcheck · University Of Minnesota · R01 · FY2025 · CA
CLINICAL TRIALS OF ALLOGENEIC STEM CELL TRANSPLANT IN LYMPHOHEMATOPOIETIC DISORDE
$440,614Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$440,580Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2019 · CA
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells
$440,560Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2024 · CA
Engineered Ensemble Nanoimmunotherapies for Cancer
$440,543Rohan Fernandes · George Washington University · R37 · FY2019 · CA
Defining the role of CNPY2 in promoting tumor progression through mediation of macrophage.
$440,520Feng Hong · Ohio State University · R01 · FY2024 · CA
An integrated polymeric carrier for subunit cancer vaccines
$440,520Suzie H Pun · University Of Washington · R01 · FY2022 · CA
T Cell Homeostasis
$440,514Stephen C Jameson · University Of Minnesota · R01 · FY2025 · AI
TOLERANCE INDUCTION IN PANCREATIC ISLET TRANSPLANTATION
$440,437University Of Illinois At Chicago · R01 · FY2000 · DK
Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes
$440,384Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2015 · HL
SOUTHWEST ONCOLOGY GROUP CA-13612
$440,336University Of Arizona · U10 · FY2002 · CA
Characterization of a novel chimeric autoantigen receptor (CAAR) treatment for Graves' disease
$440,333K. Scott Weber · Brigham Young University · R15 · FY2025 · AI
Lung Cancer Vaccine
$440,288Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2023 · CA